MedinCell S.A. / Fundamentals

    Income statement

    Net revenue
    €24.05M
    Cost of goods sold
    -€3.28M
    Gross profit
    €27.33M
    SG&A expenses
    €23.23M
    R&D expenses
    €43.28M
    EBITDA
    -€43.96M
    D&A
    €2.46M
    EBIT
    -€44.17M
    Interest expenses
    €5.08M
    EBT
    -€60.93M
    Tax expenses
    -€3.06M
    Net income
    -€57.87M

    Cash flow statement

    Net deferred tax
    -€13.19M
    Non-cash items
    €27.55M
    Changes in working capital
    €28.59M
    Operating cash flow
    -€6.33M
    Capex
    €1.37M
    Other investing cash flow
    -€5.11M
    Net investing cash flow
    -€6.16M
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €24.11M
    Debt repayment
    €8.25M
    Other financing cash flow
    €22.71M
    Net financing cash flow
    €32.39M
    Foreign exchange effects
    -€1.00K
    Net change in cash
    €9.80M
    Cash at end of period
    €31.64M
    Free cash flow
    -€4.96M

    Balance sheet

    Cash and cash equivalents
    €31.64M
    Cash and short-term investments
    €38.85M
    Total receivables
    €2.82M
    Inventory
    €0.00
    Other current assets
    €6.08M
    Total current assets
    €47.75M
    Property, plant & equipment
    €5.17M
    Goodwill
    €0.00
    Intangible assets
    €2.62M
    Long-term investments
    €2.76M
    Other non-current assets
    €559.00K
    Total non-current assets
    €11.11M
    Total assets
    €58.86M
    Accounts payable
    €2.37M
    Short-term debt
    €7.54M
    Other current liabilities
    €22.75M
    Total current liabilities
    €32.66M
    Long-term debt
    €61.65M
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €18.59M
    Total non-current liabilities
    €80.24M
    Total liabilities
    €112.89M
    Common stock
    €291.00K
    Retained earnings
    -€14.57M
    Other equity
    -€70.91M
    Total equity
    -€54.03M
    Total liabilities and shareholders' equity
    €58.86M

    Company information

    Market capitalization
    €555.22M
    Employees
    131
    Enterprise Value
    €556.41M

    Company ratios

    Gross margin
    113.6% Much better than peer group: -554.8%
    EBITDA margin
    -182.8% Much better than peer group: -12,143.6%
    EBIT margin
    -183.7% Much better than peer group: -19,093.7%
    EBT margin
    -253.4% Much better than peer group: -18,977.5%
    Net margin
    -240.6% Much better than peer group: -17,686.4%
    ROE
    107.1% Worse than peer group: 117.1%
    ROA
    -98.3% Much worse than peer group: -57.6%
    Asset turnover
    40.9% Worse than peer group: 60.6%
    FCF margin
    -32.0% Much better than peer group: -15,071.8%
    FCF yield
    -1.4%
    Efficiency ratio
    282.8%
    Net sales per employee
    €183.56K
    Net income per employee
    -€441.75K

    Notifications